top of page

Antiretroviral Therapy Reduces Mental Health Risks in US HIV Patients

HIV Treatment with Antiretroviral Therapy Mitigates the High Risk of Mental Health Disorders Associated with HIV Infection in US Population

Abstract

Introduction Whether treatment of HIV with ART is associated with lower risk of MHD among people living with HIV (PLWH) remains unknown. We aim to determine the association between HIV and MHD and whether ART alters the risk of MHD among PLWH in the US adult population.


Methods We conducted a real-world study using the MerativeTM MarketScan® claims database (2016-2020), identifying individuals with HIV diagnosed using the ICD-10 codes and those without HIV. A multivariable stratified Cox proportional hazards regression model was conducted to examine the association of HIV treatment status with MHD, adjusting for potential confounders. Additionally, we sought to determine the effect of modification of ART.


Results A total, of 313,539 individuals, mean age ([SD] of 44.2 [11.4] years), predominantly males (81.2%), residing in the South region of the US (50.9%) were included in the present analysis. During 671,880 person-years of follow-up, 46,235 incident MHD cases occurred. In the multivariable Cox proportional hazard model, PLWH was associated with higher risk of incident MHD. Relative to those without HIV, the adjusted HR was 1.85 (95% CI, 1.79–1.92; P < 0.001) for those with HIV on treatment, and 2.70 (95% CI, 2.59–2.82; P < 0.001) for those with HIV without any treatment. Stronger associations between HIV and MHD were observed in men relative to women, among those aged 18-34 relative to those aged 55-63, and those with no overweight/obesity relative to obese individuals (P-interaction <0.001 for all).


Conclusions HIV was associated with an increased risk of developing MHD. However, HIV treatment mitigated the risk.


Antiretroviral Therapy Reduces Mental Health Risks in US HIV Patients
Antiretroviral Therapy Reduces Mental Health Risks in US HIV Patients


Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
HIV and Mental Health Platform
www.eatg.org

Contact us

Interoffices | Avenue des Arts 56-4c, 1000 Brussels, Belgium

General Inquiries: +32 2 626 96 40

Be the first to know! Join the mailing list.

Thanks for subscribing!

The HIV & Mental Health project has been developed by the EATG, and was made possible through a grant from Gilead Sciences Europe Ltd, Merck Sharp and Dohme, and ViiV Healthcare Europe Ltd. . EATG acknowledges that the sponsors had no control or input into the structure or the content of the initiative.

by EATG

bottom of page